From $1M to $30M GMV: How Protege Found Product Market Fit

Bobby Samuels raised a $10M seed with almost no revenue pipeline, then grew Protege 30x to $30M GMV in year two. His story is a masterclass in founder-led enterprise sales, scrappy iteration, and knowing when the market is truly pulling you.

Key Facts

• GMV Growth: $1M in 2024 to $30M in 2025 — a 30x increase in one year (Bobby Samuels)
• Seed Round: $10M raised with almost no demand pipeline in Q3 2024 (Bobby Samuels)
• Series A: $30M raised from a16z following the 30x GMV growth (Episode Description)
• Data Network: 250+ data partners across healthcare, video, audio, and motion capture (Bobby Samuels)
• Team Size: Approximately 55 employees at the time of recording (Bobby Samuels)

What Product Market Fit Really Feels Like in AI

Product market fit in AI is not a single moment—it's when multiple deals close across different customer types simultaneously, creating a sense of undeniable momentum. For Bobby, it was Q1 2025 when several labs and non-labs signed, signaling the thesis was validated.

Bobby Samuels describes product market fit in terms of magnetism rather than milestones. Before Q1 2025, Protege had closed deals, but each one felt patched together. The team wasn't sure what was repeatable. Then, within a single quarter, deals of varying sizes landed across multiple verticals and customer types—and the pattern became undeniable.

What made Q1 different wasn't one huge win. It was the breadth. As Bobby explains, if it had been just one big deal, that would have felt good—but it wouldn't have felt like pull. The combination of consistent messaging resonating across labs, foundation model builders, and others was the real signal.

Bobby also cautions that PMF in AI is more fleeting than in previous eras. The market evolves so fast that 'we found product market fit and now let's scale' is a dangerous mindset. Q2 2025 was softer—but because Q1 had provided enough data points, the team kept running its playbook without panicking.

"Product market fit is when you're feeling the market really pulling you and there's a sense of, we've done this before, we can do it again. Where it feels like there's sort of this momentum behind you." — Bobby Samuels

"If you're in the AI world and you say I've figured it out, you are either lying to yourself or to others. The environment moves so unbelievably quickly that you just have to be really nimble." — Bobby Samuels

How In-Person Sales Became Protege's #1 Growth Driver

Bobby flew from New York to visit buyers weekly. He found that personal presence—not just digital outreach—built the trust needed to close seven-figure deals. His litmus test: if you're not on texting terms with the buyer, the relationship isn't strong enough.

Early in Protege's go-to-market phase, Bobby tried selling remotely. It didn't move fast enough. The insight that changed everything was simple: show up. In a world where AI budgets are large but buyers are bombarded with pitches, physically being there signals genuine investment in the relationship.

One early partner asked Bobby if he had relocated. He hadn't—he was just flying in every week from New York. That consistency became a trust signal more powerful than any deck or demo. For deals in the mid-to-high seven-figure range, that trust is often the deciding factor.

Bobby formalized this into a team-wide litmus test: are you on texting terms with the buyer? If not, the relationship isn't where it needs to be. This simple heuristic helped Protege's growing sales team self-assess the depth of every deal in the pipeline.

"The litmus test that I used initially, and then I used for other folks on the team is, are you on texting terms with them, with the buyer? If you were not on texting terms with someone, I am worried we don't actually have the relationship we need." — Bobby Samuels

"Look, I'm hauling my way all the way over from New York to be here and to see you. That is a clear investment in what you are doing and the relationship." — Bobby Samuels

• Weekly in-person visits built credibility that remote outreach couldn't replicate.
• Time is the ultimate trust signal—buyers notice when a founder flies across the country.
• 'Texting terms' with a buyer = relationship strong enough to close.
• Enterprise deals at seven figures require demonstrated personal commitment, not just good product.

Building the Data Network: Unfair Advantage and the Path of Least Resistance

Protege's data network—now 250+ partners—was built by leveraging Bobby's existing healthcare relationships. The playbook: find people who already trusted you, offer a no-lose rev-share model, and optimize for speed over margin in the early days.

Before Protege could sell to AI labs, it needed data. Bobby's background running a privacy business in healthcare gave him the relationships to move fast. What might have taken a year to build from scratch took weeks, because the trust was already there. This unfair advantage—knowing the health data world and the people in it—was the foundation of everything that followed.

The pitch to data partners was straightforward: you're already licensing data to pharma companies, here's a new channel with no downside. Protege took a revenue share, gave partners full control over who used their data and for what, and backed it all with Bobby's credibility. As he puts it, it was a 'no-lose' proposition for partners who already trusted him.

Protege has since expanded to video (partnering with ex-Hollywood licensing executives), audio, and motion capture—applying the same playbook each time. Find operators with deep industry networks and pre-existing trust, then leverage those networks to build the data supply quickly. The company expects to grow its partner count 50–100% this year.

"Today, your business is focused on working with primarily pharma. We can open up this whole new channel for you. We'll take a rev share or admit the rest back to you. You should trust us because you know me." — Bobby Samuels

"It would have taken a year plus to build that trust in those relationships. It took us, in most cases, we already had the relationships. We can move extremely fast." — Bobby Samuels

Ignoring the 'No': How Protege Closed Its First Major Lab Deal

When a major AI lab emailed to say Protege's data didn't meet their needs, Bobby didn't accept the rejection. He reframed the response as feedback, proposed alternatives, and ultimately closed the deal—demonstrating that scrappiness and not accepting 'no' at face value can unlock enterprise deals.

Protege's first major lab deal almost didn't happen. The lab had budget to deploy, but their research team's requirements kept shifting. Then came the email: the data didn't work, thanks but maybe another time. Bobby's response was to treat the 'no' as unfinished feedback rather than a closed door.

He went back with specifics—if you need five types of data together, here's how we can combine what we have and bring in additional partners to deliver that. The lab's team, impressed by the pivot, re-engaged. The deal closed.

This story encapsulates something Bobby returns to repeatedly: in early-stage enterprise sales, the founder's job is to try every door, find every angle, and refuse to let a soft rejection end the conversation. The scrappiness isn't just hustle—it demonstrates to buyers that you're genuinely committed to solving their problem.

"We got an email from the lab saying, hey, the data you have doesn't work for us. We're really sorry but we'd love to work with you in the future and I basically ignored the no." — Bobby Samuels

"You got to be scrappy and hustle and, like, all of these cliches, like, they're cliches." — Bobby Samuels

Why A-Plus Talent Is Worth Blowing Your Budget For

Bobby's hiring philosophy is clear: find the best person for your stage, then figure out how to pay them. The gap between A and A-plus talent is so large that overpaying is almost always worth it—especially in the early roles that define a company's trajectory.

As Protege scaled, Bobby faced the classic early-stage hiring tension: set a budget and hire within it, or identify the best person and find a way to make it work. He firmly believes in the latter. The caveat is that 'best person' means best for your stage—not the highest-paid executive at a Fortune 500.

Bobby uses a telling filter: if a candidate for an early-stage role demands a million-dollar comp package, that itself signals a mismatch. The right A-plus hire at an early-stage company understands the context and is energized by it—not just chasing a comp ceiling.

He draws the analogy to the NBA draft: the gap between the first and second pick is often enormous, and while hiring isn't a perfect analogy, the principle holds. Exceptional early team members compound in value. Bobby ran Protege's sales himself for the first year and a half before bringing in a Chief Commercial Officer—and when he did, he hired for the best fit, not the lowest cost.

"In general, for talent, the difference between A and A plus is just so massive that it's usually worth it to spend the extra money to get that person." — Bobby Samuels

"If you think about the NBA draft, the gap between the number one pick and the number two pick is usually massive. Great talent is almost always worth paying up for." — Bobby Samuels

• Hire the best person for your stage—not the cheapest person within a preset budget.
• If a candidate needs million-dollar comp at an early-stage company, they likely don't get the stage.
• A-plus vs. A talent gap is massive—the premium is almost always worth it.
• Early hires compound: the first few roles are disproportionately critical to trajectory.

Two Approaches to Startup Hiring